Emerging Antiarrhythmic Drugs for Atrial Fibrillation is a research paper published in International Journal of Molecular Sciences (2022). On theSindex it has a DataRank of 0.596. It has been cited 52 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.596
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →The Independent Research Fund Denmark
Grant: 102900011B
The Netherlands Organization for Scientific Research NWO/ZonMW Vidi
Grant: 09150171910029
The National Institutes of Health
Grant: R01HL136389
The National Institutes of Health
Grant: R01HL131517
The National Institutes of Health
Grant: R01HL089598
The German Research Foundation
Grant: DFG, Do 769/4-1
European Commission
Grant: 965286
Machine Learning Artificial Intelligence Early Detection Stroke Atrial Fibrillation
National Institutes of Health
Grant: 5R01HL131517-02
Perturbed Sodium and Calcium Fluxes in Atrial Fibrillation
National Institutes of Health
Grant: 5R01HL089598-09
CaMKII Regulation of Cardiac Ryanodine Receptors in Atrial Fibrillation
National Institutes of Health
Grant: 3R01HL136389-06S1
The Role of Gasdermin-D/Interleukin-1 Nexus in Atrial Arrhythmogenesis
FWCI
7.38
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals